Archive · 9 Dec 2025
Odisha Pharma Summit 2025: A Defining Moment for Eastern India
Odisha is hosting a big event called the Odisha Pharma Summit in 2025.
This event aims to bring lots of investments and create many jobs in the pharmaceutical and MedTech sectors.
The state wants to become a major player in making medicines and medical devices.
Odisha has different regions that can support various parts of the pharmaceutical industry, like making medicines, doing research, and exporting products.
The government promises to create 2.5 lakh jobs and bring in a lot of money to help the state grow.
However, there are challenges, like making sure the promises are kept and ensuring the state has the right infrastructure and skilled workers.
If successful, this summit could help Odisha and eastern India grow economically and reduce unemployment.
Odisha is hosting the Odisha Pharma Summit 2025 to attract investments and create 2.5 lakh jobs in the pharmaceutical and MedTech sectors.
The summit aims to integrate Odisha into India’s pharmaceutical growth story and aligns with the Prime Minister’s Purvodaya vision for industrial resurgence in eastern India.
Odisha’s different regions offer unique strengths for various aspects of the pharmaceutical industry, including logistics, research, and manufacturing.
The government promises significant job creation and investment, but past events have seen low realization of MoUs, posing a challenge for this summit.
Success will depend on execution, with the need for real factories, jobs, and GDP growth to avoid the summit being seen as an expensive spectacle.
- Who
- Odisha government and Industries Department and IPICOL
- What
- Odisha Pharma Summit 2025
- When
- 2025
- Where
- Odisha, India
- Why
- To redefine the state’s industrial trajectory and integrate Odisha into India’s pharmaceutical growth story
- Event
- Odisha Pharma Summit 2025
- Location
- Odisha, India
- Expected Jobs
- 2.5 lakh
- Expected Investment
- Rs 75,000 crores (10% of promised investments)
- GDP Growth Impact
- 2–3 percentage points annually
- Unemployment Rate
- 7-8%
- Global Drug Export Contribution
- 20% of generic drugs
- Domestic Pharma Industry Value
- Over $50 billion